Ovidio Guzmán Nears Plea Deal in U.S. Drug Trafficking Case
Mexican cartel leader Ovidio Guzmán, son of 'El Chapo,' is close to a plea deal over drug trafficking charges in the U.S. The charges include fentanyl trafficking, which caused around 50,000 overdose deaths in the U.S. last year. A change of plea hearing is set for July 9.
Mexican cartel leader Ovidio Guzmán, son of notorious drug lord Joaquín 'El Chapo' Guzmán, is reportedly nearing a plea agreement in the United States. Court records from Illinois indicate that a change of plea hearing has been scheduled for July 9, as Guzmán faces fentanyl trafficking charges.
Guzmán, known as one of the leaders of the Sinaloa Cartel, alongside his brothers 'Los Chapitos,' is accused of orchestrating a vast drug trafficking network, allegedly earning millions by distributing fentanyl across the U.S. The synthetic opioid crisis claimed approximately 50,000 American lives last year.
Despite initial not guilty pleas, Guzmán's attorney, Jeffrey Lichtman, has expressed hope for a forthcoming agreement, while no terms have been publicly disclosed. The court expects a copy of the plea agreement at least three days before the scheduled hearing.
(With inputs from agencies.)
ALSO READ
U.S. Court's Tariff Ruling: A Game-Changer in Trade Policy
Key Supplier Arrested in Major Drug Trafficking Crackdown
Rise in Drug Trafficking at Mumbai Airport: A Closer Look at the Smuggling Menace
Mizoram's Battle Against Drug Trafficking Intensifies: Smugglers Seek New Routes
Punjab's High-Tech Offensive Against Drug Trafficking

